Hecht FM - Search Results

1

Cohen MS, Gay CL, Busch MP, Hecht FM. Cohen MS, et al. Among authors: hecht fm. J Infect Dis. 2010 Oct 15;202 Suppl 2:S270-7. doi: 10.1086/655651. J Infect Dis. 2010. PMID: 20846033 Review.

2

HIV Antibody Level as a Marker of HIV Persistence and Low-Level Viral Replication.

Keating SM, Pilcher CD, Jain V, Lebedeva M, Hampton D, Abdel-Mohsen M, Deng X, Murphy G, Welte A, Facente SN, Hecht F, Deeks SG, Pillai SK, Busch MP. Keating SM, et al. J Infect Dis. 2017 Jul 1;216(1):72-81. doi: 10.1093/infdis/jix225. J Infect Dis. 2017. PMID: 28498985 Free PMC article.

3

Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells.

Hatano H, Jain V, Hunt PW, Lee TH, Sinclair E, Do TD, Hoh R, Martin JN, McCune JM, Hecht F, Busch MP, Deeks SG. Hatano H, et al. J Infect Dis. 2013 Jul;208(1):50-6. doi: 10.1093/infdis/jis630. Epub 2012 Oct 22. J Infect Dis. 2013. PMID: 23089590 Free PMC article.

4

Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection.

Barbour JD, Hecht FM, Wrin T, Segal MR, Ramstead CA, Liegler TJ, Busch MP, Petropoulos CJ, Hellmann NS, Kahn JO, Grant RM. Barbour JD, et al. Among authors: hecht fm. J Infect Dis. 2004 Jul 15;190(2):251-6. doi: 10.1086/422036. Epub 2004 Jun 18. J Infect Dis. 2004. PMID: 15216458

5

Nucleic acid amplification testing for diagnosis of acute HIV infection: has the time come?

Busch MP, Hecht FM. Busch MP, et al. Among authors: hecht fm. AIDS. 2005 Aug 12;19(12):1317-9. doi: 10.1097/01.aids.0000180103.65640.d8. AIDS. 2005. PMID: 16052087 No abstract available.

6

Potential herpesvirus interaction during HIV type 1 primary infection.

Lennette ET, Busch MP, Hecht FM, Levy JA. Lennette ET, et al. Among authors: hecht fm. AIDS Res Hum Retroviruses. 2005 Oct;21(10):869-75. doi: 10.1089/aid.2005.21.869. AIDS Res Hum Retroviruses. 2005. PMID: 16225414

7

Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.

Hare CB, Pappalardo BL, Busch MP, Karlsson AC, Phelps BH, Alexander SS, Bentsen C, Ramstead CA, Nixon DF, Levy JA, Hecht FM. Hare CB, et al. Among authors: hecht fm. Clin Infect Dis. 2006 Mar 1;42(5):700-8. doi: 10.1086/500215. Epub 2006 Jan 23. Clin Infect Dis. 2006. PMID: 16447118

8

Identifying the early post-HIV antibody seroconversion period.

Hecht FM, Wellman R, Busch MP, Pilcher CD, Norris PJ, Margolick JB, Collier AC, Little SJ, Markowitz M, Routy JP, Holte S; Acute Infection Early Disease Research Program. Hecht FM, et al. J Infect Dis. 2011 Aug 15;204(4):526-33. doi: 10.1093/infdis/jir304. J Infect Dis. 2011. PMID: 21791654 Free PMC article.

9

Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.

Jain V, Hartogensis W, Bacchetti P, Hunt PW, Hatano H, Sinclair E, Epling L, Lee TH, Busch MP, McCune JM, Pilcher CD, Hecht FM, Deeks SG. Jain V, et al. Among authors: hecht fm. J Infect Dis. 2013 Oct 15;208(8):1202-11. doi: 10.1093/infdis/jit311. Epub 2013 Jul 12. J Infect Dis. 2013. PMID: 23852127 Free PMC article.

10

Use of laboratory tests and clinical symptoms for identification of primary HIV infection.

Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. Hecht FM, et al. AIDS. 2002 May 24;16(8):1119-29. doi: 10.1097/00002030-200205240-00005. AIDS. 2002. PMID: 12004270 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

609 results

Search Page